| Product NDC: | 68016-085 | 
| Proprietary Name: | Premier Value | 
| Non Proprietary Name: | Loratadine | 
| Active Ingredient(s): | 5 mg/5mL & nbsp; Loratadine | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 68016-085 | 
| Labeler Name: | Chain Drug Constortium | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | ANDA076805 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20040820 | 
| Package NDC: | 68016-085-08 | 
| Package Description: | 1 BOTTLE in 1 CARTON (68016-085-08) > 120 mL in 1 BOTTLE | 
| NDC Code | 68016-085-08 | 
| Proprietary Name | Premier Value | 
| Package Description | 1 BOTTLE in 1 CARTON (68016-085-08) > 120 mL in 1 BOTTLE | 
| Product NDC | 68016-085 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Loratadine | 
| Dosage Form Name | SOLUTION | 
| Route Name | ORAL | 
| Start Marketing Date | 20040820 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Chain Drug Constortium | 
| Substance Name | LORATADINE | 
| Strength Number | 5 | 
| Strength Unit | mg/5mL | 
| Pharmaceutical Classes |